Leading medical device company presents real-world use of InPen™ on glycemic and insulin design outcomes. CONTEXT: Amongst the 7 data presentations at this year’s American Diabetes Association meeting will be findings Continue Reading
A new real-world research study evaluates the safety profile and discontinuation rates of Cosentyx (secukinumab) in patients with axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA) CONTEXT: This report published in Continue Reading
Unexpected, but welcome, inclusion in Cures 2.0 of provision for real-world evidence in evaluation of safety and efficacy of pharmaceutical products. CONTEXT: The follow-up to the U.S 21st Century Cures Continue Reading
CONTEXT: Interesting article on Google’s continuing move into health tech with their dermatology AI app. The “device” fairs better than dermatologists at recognising skin conditions, apparently, although there are no Continue Reading
CONTEXT: Who knew that mood altering compounds might alter your mood – but in a good way? We’ve included this nice coffee break moment article on the renewed interest in Continue Reading
CONTEXT: Announcement from Gilead that analyses of three real-world data sets (2 US and 1 global) showed remdesivir lowered the risk of mortality in hospitalised COVID patients. The studies included Continue Reading
CONTEXT: Commercial announcement from PCM trials of the opening of a London office to better serve their decentralised trial offering in Europe. IMPACT: Low READ TIME: 1 min Quality Level Continue Reading
CONTEXT: Presentation of a non-interventional study on breastfeeding mothers with Relapsing Multiple Sclerosis (MS) taking Copaxone at the 7th annual congress of the European Academy of Neurology (EAN). Around a Continue Reading
CONTEXT: Commercial announcement – Syneos expands its decentralised trial offering IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 3 ” TRIALS & FILINGS Novavax COVID-19 Vax Continue Reading
CONTEXT: Publication of analysis from an ongoing 5-year longitudinal observational study of more than 4,400 patients with inflammatory bowel disease (IBD) in the Journal of Clinical Gastroenterology. This paper includes Continue Reading
